Buscar
Mostrando ítems 1-1 de 1
Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
(CELL PRESS, 2019)
PTEN expression is lost in many cancers, and even small changes in PTEN activity affect susceptibility and prognosis in a range of highly aggressive malignancies, such as melanoma and triple-negative breast cancer (TNBC). ...